News & Events​

Featured News​

January 6, 2026

January 6, 2026

E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.’s ~$5.5 Million Private Placement

MANHATTAN, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a Manhattan-headquartered investment bank and broker-dealer, today announced that it acted as the exclusive placement agent in connection with iSpecimen Inc.’s (Nasdaq: ISPC) private placement, raising approximately $5.5 million in gross proceeds before fees and expenses.

December 30, 2025

December 30, 2025

iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement

WOBURN, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers,

December 23, 2025

December 23, 2025

E.F. Hutton Advises on RPM Interactive’s Acquisition by Avalon GloboCare

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a leading investment bank providing strategic advisory and capital markets services, today is proud to have served as exclusive financial advisor to RPM Interactive, Inc.

December 17, 2025

December 17, 2025

E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton is proud to have served as an Exclusive M&A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: APUS) and Mindwave Innovations Inc.

recent transactions

Contact Us

Your needs are important to us. Take a moment to complete the form, and we'll make sure to contact you as soon as possible.

    Multi-Level Sidebar